Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Depreciation and Depletion: 2022-2023

Historic Depreciation and Depletion for Candel Therapeutics (CADL) over the last 1 years, with Dec 2023 value amounting to $289,000.

  • Candel Therapeutics' Depreciation and Depletion rose 18.93% to $289,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $919,000, marking a year-over-year change of. This contributed to the annual value of $1.0 million for FY2024, which is negligibly% changed negligibly from last year.
  • According to the latest figures from Q4 2023, Candel Therapeutics' Depreciation and Depletion is $289,000, which was up 44.50% from $200,000 recorded in Q3 2023.
  • Candel Therapeutics' Depreciation and Depletion's 5-year high stood at $289,000 during Q4 2023, with a 5-year trough of $200,000 in Q2 2023.
  • Moreover, its 2-year median value for Depreciation and Depletion was $230,000 (2023), whereas its average is $232,400.
  • Data for Candel Therapeutics' Depreciation and Depletion shows a peak YoY rose of 18.93% (in 2023) over the last 5 years.
  • Candel Therapeutics' Depreciation and Depletion (Quarterly) stood at $243,000 in 2022, then climbed by 18.93% to $289,000 in 2023.
  • Its Depreciation and Depletion was $289,000 in Q4 2023, compared to $200,000 in Q3 2023 and $200,000 in Q2 2023.